Status and phase
Conditions
Treatments
About
Determine the feasibility of liver stereotactic body radiation therapy (SBRT) given in combination with systemic therapy (immune checkpoint inhibitors) in adult patients with metastatic NSCLC with liver metastases.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
12 participants in 1 patient group
Loading...
Central trial contact
Michael Green, MD; Shaneta Waddy, MHA
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal